J Pediatr Intensive Care 2017; 06(03): 159-164
DOI: 10.1055/s-0036-1596064
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Catheter-Associated Blood Stream Infections in Intracardiac Lines

Xiomara Garcia
1   Pediatric Critical Care Medicine and Cardiology, Arkansas Children's Hospital, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
,
Sherry Pye
2   Pediatric Cardiology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
,
Xinyu Tang
3   Pediatrics-Biostatistics, University of Arkansas for Medical Sciences, Arkansas Children's Hospital, Little Rock, Arkansas, United States
,
Jeffrey Gossett
3   Pediatrics-Biostatistics, University of Arkansas for Medical Sciences, Arkansas Children's Hospital, Little Rock, Arkansas, United States
,
Parthak Prodhan
1   Pediatric Critical Care Medicine and Cardiology, Arkansas Children's Hospital, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
,
Adnan Bhutta
4   Pediatric Critical Care Medicine, University of Maryland School of Medicine, Baltimore, Maryland, United States
› Author Affiliations
Further Information

Publication History

20 June 2016

22 October 2016

Publication Date:
05 December 2016 (online)

Abstract

Purpose Right atrial (RA) or intracardiac lines are commonly used for hemodynamic monitoring in children undergoing cardiac surgery. In some institutions, these lines are used as the preferred long-term access line due to concerns for catheter-associated blood stream infections (CABSI) and catheter-related venous thrombosis with central lines in other locations. However, the rates and risk factors for CABSI and other complications are not known for RA lines. We undertook this study to estimate CABSI rates for RA lines in comparison with central catheters of various types and locations and to evaluate the incidence of other complications associated with the use of RA lines.

Methods After approval from the Institutional Review Board, a retrospective review of all patients undergoing cardiac surgery at Arkansas Children's Hospital between the dates of January 1, 2006 and December 31, 2011 was performed. Demographic data, clinical features, and outcomes were summarized on a per-patient level. Type, location of placement, and duration of all centrally placed catheters as well as associated complications were recorded. Central venous lines (CVL) used in our unit include peripherally inserted central catheters (PICC) lines, and antibiotic and heparin coated double or triple lumen lines placed in internal jugular (IJ), femoral (Fem), or RA positions. The data were analyzed using statistical software STATA/MP.

Results A total of 2,736 central lines were used in 1,537 patients. Data on line duration, alteplase use, and percentage of lines developing CABSI are described in the study. Disease severity as assessed by risk-adjusted classification for congenital heart surgery (RACHS) score (p < 0.046), year of placement (p < 0.001), and line type adjusted for thrombolytic (alteplase) use are significantly associated with risk of any CABSI. Overall, IJ and RA lines had least risk of CABSI while PICC lines had the highest CABSI rates. RA lines are also associated with other medically significant complications.

Conclusion The CABSI rates associated with RA lines are lower than those seen with PICC lines. However, RA line use is associated with other, potentially significant complications. RA lines may be used cautiously as long-term access lines in cardiac patients in whom it is important to preserve venous patency for future interventions.

 
  • References

  • 1 Gold JP, Jonas RA, Lang P, Elixson EM, Mayer JE, Castaneda AR. Transthoracic intracardiac monitoring lines in pediatric surgical patients: a ten-year experience. Ann Thorac Surg 1986; 42 (02) 185-191
  • 2 Flori HR, Johnson LD, Hanley FL, Fineman JR. Transthoracic intracardiac catheters in pediatric patients recovering from congenital heart defect surgery: associated complications and outcomes. Crit Care Med 2000; 28 (08) 2997-3001
  • 3 Miller JW, Vu DN, Chai PJ. , et al. Upper body central venous catheters in pediatric cardiac surgery. Paediatr Anaesth 2013; 23 (11) 980-988
  • 4 CDC. Vital signs. Making healthcare safer: reducing bloodstream infections. March 2011. Available at: http://www.cdc.gov/VitalSigns/HAI/index.html
  • 5 Wylie MC, Graham DA, Potter-Bynoe G. , et al. Risk factors for central line-associated bloodstream infection in pediatric intensive care units. Infect Control Hosp Epidemiol 2010; 31 (10) 1049-1056
  • 6 Bhutta A, Gilliam C, Honeycutt M. , et al. Reduction of bloodstream infections associated with catheters in paediatric intensive care unit: stepwise approach. BMJ 2007; 334 (7589): 362-365
  • 7 Baskin JL, Reiss U, Wilimas JA. , et al. Thrombolytic therapy for central venous catheter occlusion. Haematologica 2012; 97 (05) 641-650
  • 8 Baskin JL, Pui CH, Reiss U. , et al. Management of occlusion and thrombosis associated with long-term indwelling central venous catheters. Lancet 2009; 374 (9684): 159-169
  • 9 Rowan CM, Miller KE, Beardsley AL. , et al. Alteplase use for malfunctioning central venous catheters correlates with catheter-associated bloodstream infections. Pediatr Crit Care Med 2013; 14 (03) 306-309
  • 10 Johnston LJ, McKinley DF. Cardiac tamponade after removal of atrial intracardiac monitoring catheters in a pediatric patient: case report. Heart Lung 2000; 29 (04) 256-261
  • 11 Darling JC, Newell SJ, Mohamdee O, Uzun O, Cullinane CJ, Dear PR. Central venous catheter tip in the right atrium: a risk factor for neonatal cardiac tamponade. J Perinatol 2001; 21 (07) 461-464
  • 12 Jenkins KJ, Gauvreau K, Newburger JW, Spray TL, Moller JH, Iezzoni LI. Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg 2002; 123 (01) 110-118